Extracellular RNA in melanoma: Advances, challenges, and opportunities
- PMID: 37215082
- PMCID: PMC10192583
- DOI: 10.3389/fcell.2023.1141543
Extracellular RNA in melanoma: Advances, challenges, and opportunities
Abstract
Melanoma, a malignant mass lesion that originates in melanocytes and has a high rate of malignancy, metastasis, and mortality, is defined by these characteristics. Malignant melanoma is a kind of highly malignant tumor that produces melanin and has a high mortality rate. Its incidence accounts for 1%-3% of all malignant tumors and shows an obvious upward trend. The discovery of biomolecules for the diagnosis and treatment of malignant melanoma has important application value. So far, the exact molecular mechanism of melanoma development relevant signal pathway still remains unclear. According to previous studies, extracellular RNAs (exRNAs) have been implicated in tumorigenesis and spread of melanoma. They can influence the proliferation, invasion and metastasis of melanoma by controlling the expression of target genes and can also influence tumor progression by participating in signal transduction mechanisms. Therefore, understanding the relationship between exRNA and malignant melanoma and targeting therapy is of positive significance for its prevention and treatment. In this review, we did an analysis of extracellular vesicles of melanoma which focused on the role of exRNAs (lncRNAs, miRNAs, and mRNAs) and identifies several potential therapeutic targets. In addition, we discuss the typical signaling pathways involved in exRNAs, advances in exRNA detection and how they affect the tumor immune microenvironment in melanoma.
Keywords: RNA; dermatology; exosomes; melanoma; tumor environment (TME).
Copyright © 2023 Li, Gao, Cao, He, Jiang, Liu, Cai and Zan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Extracellular RNA in Central Nervous System Pathologies.Front Mol Neurosci. 2019 Oct 17;12:254. doi: 10.3389/fnmol.2019.00254. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31680858 Free PMC article. Review.
-
Non-coding RNAs in melanoma: Biological functions and potential clinical applications.Mol Ther Oncolytics. 2021 Jun 4;22:219-231. doi: 10.1016/j.omto.2021.05.012. eCollection 2021 Sep 24. Mol Ther Oncolytics. 2021. PMID: 34514101 Free PMC article. Review.
-
p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment.Cell Death Dis. 2021 Oct 28;12(11):1012. doi: 10.1038/s41419-021-04311-5. Cell Death Dis. 2021. PMID: 34711805 Free PMC article.
-
Identifying mRNA, microRNA and protein profiles of melanoma exosomes.PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9. PLoS One. 2012. PMID: 23056502 Free PMC article.
-
Construction of competing endogenous RNA interaction network as prognostic markers in metastatic melanoma.PeerJ. 2021 Sep 15;9:e12143. doi: 10.7717/peerj.12143. eCollection 2021. PeerJ. 2021. PMID: 34616613 Free PMC article.
Cited by
-
Exosomes in esophageal cancer: function and therapeutic prospects.Med Oncol. 2024 Nov 27;42(1):18. doi: 10.1007/s12032-024-02543-x. Med Oncol. 2024. PMID: 39601925 Review.
-
Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma.Front Oncol. 2025 Jun 17;15:1606325. doi: 10.3389/fonc.2025.1606325. eCollection 2025. Front Oncol. 2025. PMID: 40599859 Free PMC article. Review.
-
RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma.Invest New Drugs. 2024 Feb;42(1):60-69. doi: 10.1007/s10637-023-01413-z. Epub 2023 Dec 10. Invest New Drugs. 2024. PMID: 38071684
-
The tumor immune microenvironment in primary cutaneous melanoma.Arch Dermatol Res. 2025 Jan 18;317(1):273. doi: 10.1007/s00403-024-03758-8. Arch Dermatol Res. 2025. PMID: 39825956 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources